Cancer BiologyeLifePeer-reviewed
Combinatorial CRISPR screen reveals FYN and KDM4 as targets for synergistic drug combination for treating triple negative breast cancer
Tackhoon Kim, Byung-Sun Park, Soobeen Heo…·Timothy K. Lu
The paper identifies FYN and KDM4 as synergistic targets for enhancing TKI efficacy in triple negative breast cancer through CRISPR screens and mechanistic analysis.
10 citations